Search

Your search keyword '"DE RENZO, A."' showing total 71 results

Search Constraints

Start Over You searched for: Author "DE RENZO, A." Remove constraint Author: "DE RENZO, A." Topic female Remove constraint Topic: female
71 results on '"DE RENZO, A."'

Search Results

1. 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis

2. Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience

3. The double face of the same disease

4. Diagnosis of anaplastic large cell lymphoma on late peri-implant breast seroma: Management of cytological sample by an integrated approach

5. Successful and Safe Long-Term Standard Antiviral Therapy in a Patient with 'Explosive' Immune Response in Course of HCV-Related Liver Cirrhosis

6. Italian real-life experience with brentuximab vedotin: Results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma

7. Fine-needle cytology and flow cytometry immunophenotyping and subclassification of non-hodgkin lymphoma

8. Intravascular B-cell Lymphoma: Report of Two Cases with Different Clinical Presentation but Rapid Central Nervous System Involvement

9. Nuclear bcl10 expression characterizes a group of ocular adnexa MALT lymphomas with shorter failure-free survival

10. Fine needle aspiration cytology and flow cytometry immunophenotyping of non-Hodgkin lymphoma: can we do better?

11. Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma

12. Randomized comparison of power Doppler ultrasound-directed excisional biopsy with standard excisional biopsy for the characterization of lymphadenopathies in patients with suspected lymphoma

13. Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma

14. Rituximab maintenance compared with observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation in patients age older than 60 years with advanced follicular lymphoma: a phase III randomized study by the Fondazione Italiana Linfomi

15. Primary hepatic lymphoma in a patient with previous rectal adenocarcinoma: a case report and discussion ofetiopathogenesis and diagnostic tools

16. Bone Marrow uptake of 99mTc-MIBI in patients with multiple myeloma

17. Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up

18. Early Autologous Stem-Cell Transplantation Versus Conventional Chemotherapy as Front-Line Therapy in High-Risk, Aggressive Non-Hodgkin’s Lymphoma: An Italian Multicenter Randomized Trial

19. Assessment of Metabolic Response to Radioimmunotherapy with Y-90-Ibritumomab Tiuxetan in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

20. Assessment of metabolic activity by PET-CT with F-18-FDG in patients with T-cell lymphoma

21. Hepatitis C virus infection in ocular adnexal lymphomas

22. Randomized trial of 8-week versus 12-week VNCOP-B plusG-CSF regimens as front-line treatment in elderly aggressive non-Hodgkin’s lymphoma patients

23. Immunophenotype and intermediate-high international prognostic index score are prognostic factors for therapy in diffuse large B-cell lymphoma patients

24. Cyclophosphamide, doxorubicin, vincristine, methotrexate, bleomicin and prednisone plus rituximab in untreated young patients with low-risk (age-adjusted international prognostic index 0-1) diffuse large B-cell lymphoma. Leuk Lymphoma

25. Clonal B-cell population in a reactive lymph node in acquired immunodeficiency syndrome

26. Fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in previously untreated patients with follicular non-Hodgkin lymphoma trial: a phase II non-randomised trial (FLUMIZ)

27. Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma

28. The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphoma

29. Different patterns of technetium-99m sestamibi uptake in multiple myeloma

30. Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma

31. A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma

32. Subacute combined degeneration of the spinal cord in a vegan

33. How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?

34. High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy

35. Occult hepatitis B virus infection in patients with non‐Hodgkin lymphoma: the need for early diagnosis in anti‐Hbc positive patients

36. Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans

38. Interleukin-10 - 1082 GG polymorphism influences the occurrence and the clinical characteristics ofhepatitis C virus infection

39. Risk of Non-Hodgkin Lymphoma in Celiac Disease

40. Delta-CHr improves the identification of anemic syndromes and the evaluation of hemoglobin synthesis

41. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma

42. Cytoplasmic GpIIb-IIIa and cytokine secretion by blasts in a case of megakaryoblastic transformation of essential thrombocythemia

43. Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations

44. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multi-center case-control study

45. Efficacy of rituximab in gastric diffuse large B cell lymphoma patients

46. High prevalence of hepatitis G virus infection in Hodgkin's disease and B-cell lymphoproliferative disorders: absence of correlation with hepatitis C virus infection

47. Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy

48. Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients

49. Late appearance of acanthocytes during the course of chorea-acanthocytosis

50. Acute promyelocytic leukemia after treatment for non-Hodgkin's lymphoma with drugs targeting topoisomerase II

Catalog

Books, media, physical & digital resources